
| Product Development |
| Medical Contract Manufacturing |
| Product & Process Validation |
| Concept to Customer Turnkey Service |
| Mechanical Engineering |
| Electrical & Electronic Engineering |
| Software Development |
| Verification & Validation |
| Medical Contract Manufacturing |
![]() |
|
|
History
Proven Process is unique in the medical device contract
R&D and OEM marketplace because exceptional medical device development
and manufacturing is all we do. Founded in 1994 as the East Development
Group, Proven Process has built in results for a wide variety of companies
from high profile clients such as C.R. Bard, Boston Scientific, and Pfizer
to small start-ups poised to make their names in the industry. The common
thread in each client relationship is the value Proven Process brings
from Day One, tailored to the client’s needs and maximized to the
client’s benefit.
![]() Over the years, the company has had many proud
moments, including being awarded a NIST Advanced
Technology Program grant. But the best rewards come from seeing our
clients succeed with devices brought to market with the help of Proven
Process. These include:
Pneumatic Ventricular Assist Device Line Powered
Drive Unit
– Fully implantable Ventricular Assist Device Implantable Programmable Insulin Pump
Multi-Use Hand-Held Insulin Programmer
Implantable Constant Flow Pumps
Implantable Catheter Products
Diagnostic Ancillary Equipment
Implantable Vascular Access Devices
Implantable Pacemaker Leads
Hand-Held Pacemaker Programmer
Sterile Disposable Accessories
Neurological Stimulators
Ambulatory and Pole Mounted Drug Delivery Systems
Medical Kits
Vascular Access Ports and Catheters
national institute of standards and technology/advanced technology program grant winning device Totally Implantable Blood Pressure Sensor As a joint venture, Proven Process and APEX Medical have successfully completed initial animal tests of their totally implantable blood pressure device that will optimize operations of Left Ventricular Assist Devices (LVADs). Made of titanium, the device is being developed in part with funding awarded by the U.S. Department of Commerce's National Institute of Standards and Technology/Advanced Technology Program, following a national competition.The device is the only known blood pressure monitor in development designed to fully integrate with an LVAD to assure direct, continuous measurement of blood pressure. An LVAD is used to treat congestive heart failure by working alongside a weakened heart, helping by pumping blood from the left ventricle. Five million Americans suffer from congestive heart failure today and 400,000 more are diagnosed with the disease each year. However, only about 2,500 hearts are available each year in the US for transplant, and as the population ages the incidence of heart disease is expected to increase. |